Optilume Urethral Drug Coated Balloon

FDA Premarket Approval P210020 S003

This medical device record is a pma supplement. A supplement may have changed the device description/function or indication from that approved in the original pma. Be sure to look at the original pma record for more information.

Pre-market Approval Supplement Details

Approval of the protocol for the post-approval study (pas) referenced above. The pas protocol has been submitted to comply with the conditions of approval outlined in our approval order for p210020.

DeviceOptilume Urethral Drug Coated Balloon
Generic NameCatheter, Balloon, Urethral, Drug-coated
ApplicantUrotronic, Inc.
Date Received2022-01-05
Decision Date2022-02-03
PMAP210020
SupplementS003
Product CodeQRH 
Advisory CommitteeGastroenterology/Urology
Supplement TypeNormal 180 Day Track No User Fee
Supplement ReasonPostapproval Study Protocol
Expedited ReviewNo
Combination Product Yes
Applicant Address Urotronic, Inc. 2495 Xenium Lane minneapolis, MN 55441

Supplemental Filings

Supplement NumberDateSupplement Type
P210020Original Filing
S006 2022-08-30 Normal 180 Day Track No User Fee
S005 2022-05-12 Normal 180 Day Track No User Fee
S004 2022-02-24 Real-time Process
S003 2022-01-05 Normal 180 Day Track No User Fee
S002 2021-12-28 Normal 180 Day Track No User Fee
S001 2021-12-20 Normal 180 Day Track No User Fee

NIH GUDID Devices

Device IDPMASupp
00853095008334 P210020 000
00853095008327 P210020 000
00853095008310 P210020 000
00853095008303 P210020 000
00853095008297 P210020 000
00853095008280 P210020 000
00853095008273 P210020 000
00853095008242 P210020 000

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.